UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000053925 |
|---|---|
| Receipt number | R000061554 |
| Scientific Title | Relationships between muscle sympathetic nerve activity and serum level of fatty acid binding protein 4 |
| Date of disclosure of the study information | 2024/03/21 |
| Last modified on | 2024/03/21 14:43:59 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Relationships between muscle sympathetic nerve activity and serum level of fatty acid binding protein 4
Acronym
Relationships between muscle sympathetic nerve activity and serum level of fatty acid binding protein 4
Scientific Title
Relationships between muscle sympathetic nerve activity and serum level of fatty acid binding protein 4
Scientific Title:Acronym
Relationships between muscle sympathetic nerve activity and serum level of fatty acid binding protein 4
Region
| Japan |
Condition
Condition
Healthy,Hypertension
Classification by specialty
| Medicine in general | Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In this study, we examinated about correlation between Muscle sympathetic nerve activity and Adipocyte Fatty Acid Binding Protein
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Assessment
Primary outcomes
Adipocyte Fatty Acid Binding Protein, MSNA
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Healthy or hypertensive subjects
Key exclusion criteria
Patients with an estimated glomerular filtration rate of <50ml/min/1.73m2, advanced lung disease, mental illness, severe hepatic dysfunction, severe diabetes, neurological disease, maintenance dialysis.
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Tadayuki |
| Middle name | |
| Last name | Hirai |
Organization
Kanazawa University Graduate School of Medical Sciences
Division name
Department of Cardiovascular Medicine
Zip code
9208641
Address
13 -1 Takaramachi, Kanazawa-city, Ishikawa
TEL
+81-76-265-2000
thiraikz@gmail.com
Public contact
Name of contact person
| 1st name | Tadayuki |
| Middle name | |
| Last name | Hirai |
Organization
Kanazawa University Graduate School of Medical Sciences
Division name
Department of Cardiovascular Medicine
Zip code
9208641
Address
13 -1 Takaramachi, Kanazawa-city, Ishikawa
TEL
+81-76-265-2000
Homepage URL
thiraikz@gmail.com
Sponsor or person
Institute
Kanazawa University
Institute
Department
Personal name
Funding Source
Organization
Otsuka Medical Devices Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Nothing
Address
Nothing
Tel
Nothing
Nothing
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 03 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2020 | Year | 03 | Month | 03 | Day |
Date of IRB
| 2020 | Year | 05 | Month | 25 | Day |
Anticipated trial start date
| 2020 | Year | 05 | Month | 25 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
I have finished observing 20 cases.
Management information
Registered date
| 2024 | Year | 03 | Month | 21 | Day |
Last modified on
| 2024 | Year | 03 | Month | 21 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061554
